Journal News

Removing belly fat
before it sticks to you

University of Cincinnati researchers produce fat-busting proteins in the lab
Cedric Ricks
By Cedric Ricks
March 24, 2020

Triglycerides, those fats that seem to be the bane of any diet, remain a mystery for many researchers. Plenty of them are in Big Macs, deep pan pizza and the like, but some are a necessity to fuel the body for daily activities.

Researchers Mark Castleberry, a doctoral student, and professor Sean Davidson, both in the University of Cincinnati College of Medicine, have found a way to produce in the laboratory a human protein produced in the liver known as apolipoprotein A5, or APOA 5. It plays an important role in metabolizing and clearing excess levels of triglycerides from the bloodstream.

Their findings were published in the Journal of Lipid Research. Castleberry, who is studying in the UC department of molecular genetics, biochemistry and microbiology, is the paper’s first author.

 

Colleen Kelley/UC Creative Services
Mark Castleberry, a doctoral student, and Sean Davidson are pictured in Davidson's lab at the University of Cincinnati College of Medicine

“We are really interested in understanding triglycerides because hypertriglyceridemia — too much fat in your blood — is a big factor leading to cardiovascular disease, diabetes, obesity and other health concerns,” explains Davidson, who holds appointments in UC’s departments of pathology and laboratory medicine and molecular genetics, biochemistry and microbiology. “When you have a lot of fat that is hanging around in your circulation it’s important to clear as much of it out as soon as possible.”

“APOA5 is highly involved in how fast triglycerides get taken out of your circulation,” says Davidson, who has a doctorate in biochemistry. “The more APOA5 you have the faster the triglyceride is removed. Everybody agrees it is an important protein but scientists don’t know much about its structure or how it does what it does. If we could figure out how it works we could come up with a drug that uses the same mechanism or trigger it to work better.”

The work demonstrates UC's commitment to research as described in its strategic direction called Next Lives Here.

Castleberry says researchers inserted a human gene coded by DNA into bacteria genetically engineered to produce human proteins. Once those proteins were produced they were removed from the host and purified for use in studies at the lab bench and in mouse models.

“We can quickly make a much greater amount of this protein using bacterial production than if we tried to isolate it from blood in humans,” explains Castleberry. “The mice in this study were basically fed a large bowl of fat and triglycerides.”

“We could analyze their blood after we fed them and observe the level of fat change as they digested the meal,” said Castleberry. “We were able to give our protein to the mice that had that fatty meal and rapidly clear the triglycerides that would have accumulated in their blood.”

Other co-authors of this study were Xenia Davis; Thomas Thompson, a professor in UC’s department of molecular genetics, biochemistry and microbiology, and Patrick Tso and Min Liu, both professors in UC’s department of pathology and laboratory medicine. 

The research was supported by the National Institutes of Health’s Heart, Lung and Blood Institute, which funded a predoctoral fellowship for Castleberry.

This article was originally published on the UC News page. Read it here.
 
Sean Davidson, an associate editor of the Journal of Lipid Research, recently talked to staff writer Laurel Oldach about his fascination with high-density lipoprotein and why he cringes when people call it “good cholesterol.”  Also, his love of competitive cycling. Read the ASBMB Today interview.

 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Cedric Ricks
Cedric Ricks

Cedric Ricks is a public information officer at the University of Cincinnati.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader–Willi syndrome.

Using 'nature’s mistakes' as a window into Lafora disease
Feature

Using 'nature’s mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer’s code through functional connections
News

Cracking cancer’s code through functional connections

July 2, 2025

A machine learning–derived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.

Bacterial enzyme catalyzes body odor compound formation
Journal News

Bacterial enzyme catalyzes body odor compound formation

June 27, 2025

Researchers identify a skin-resident Staphylococcus hominis dipeptidase involved in creating sulfur-containing secretions. Read more about this recent Journal of Biological Chemistry paper.

Neurobiology of stress and substance use
Profile

Neurobiology of stress and substance use

June 19, 2025

MOSAIC scholar and proud Latino, Bryan Cruz of Scripps Research Institute studies the neurochemical origins of PTSD-related alcohol use using a multidisciplinary approach.